Saratov JOURNAL of Medical and Scientific Research

Nervous system diseases comorbid to psoriasis

Year: 2016, volume 12 Issue: №2 Pages: 300-303
Heading: Neurology Article type: Review
Authors: Fisun A.V., Kolokolov O.V., Bakulev A.L., Makarov N.S., Kravchenya S.S., Schabogina A.A., Popova O.V.
Organization: Saratov State Medical University

The information about the cormorbid pathology in patients with skin and nervous systems diseases is summarized on the base of Russian and foreign scientific literature. The main attention is devoted to the combination of nervous system pathology with psoriasis and psoriatic arthritis. The high risk of cerebrovascular diseases development is pointed in psoriasis. Material concerning neuropathy caused by the cytostatics usage is represented in patients with psoriasis.

1. Belyalov F.l. Twenty thesis of comorbidity. Clinical medicine 2009; 12: 69-71
2. Vertkin A.L., Zairatsyanz O.V., Vovk E.l. Final diagnosis. M.: GEOTAR, 2008;574 p.
3. Fortin М, et al. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2004; 20 (2): 51
4. Bakulev A.L., Shtoda U.M., Utz S.R. On the question of comorbidity in psoriasis. Saratov Journal of Medical Scientific Research 2014; 10 (3): 537-539
5. Schwandt A, et al. Psoriasis and Diabetes: A Multicenter Study in 222078 Type 2 Diabetes Patients Reveals High Levels of Depression. Journal of Diabetes Research Volume 2015; Article ID 792968, 10 pages
6. Phan C, et al. Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases. Ann Dermatol Venereol 2016; 143 (4): 264-274
7. Kungurov N.V., Filimonkova N.N., Topichkanova E.P., Kiseleva N.V., Kohan M.M. Comorbid cardiovascular pathology in patients with psoriasis vulgaris. Lechaschiy Vrach Journal 2014; (9)
8. Zhuk A.N., Morrison A.V., Eremina M.G. Psorisis and cardiovascular syndrome: commom causes (cinical observation).
9. Griffiths СЕМ, Barker JNWN. Pathogenesis and clinical features of psoriasis. Lancet 2007; 370: 263-371
10. Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999; 41: 401-407
11. Ruth AM, Nadia R, Jeffrey C, et al. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Multiple Sclerosis Journal 2015; 21 (3): 282-293
12. FellnerA, DanoM, Regev K, MosekA, Kami A. Multiple sclerosis is associated with psoriasis: A case-control study. J Neurol Sci 2014; 338 (1 -2): 226-8. doi: 10.1016/j.jns.2014.01.003
13. Kolb-Maurer A, Goebeler M, Maurer M. Cutaneous Adverse Events Associated with lnterferon-p Treatment of Multiple Sclerosis. Int J Mol Sci 2015; 16 (7): 14951-60. doi: 10.3390/ijms160714951
14. Marco G, Marina Ti, Alessandro DS, et al. Linear psoriasis following the typical distribution of the sciatic nerve. J Dermatol Case 2015; 9 (1): 6-11
15. Chroni E, MonastirliA, Georgiou S, etal. Sensorimotor polyneuropathy after a 1 -month treatment with oral acitretin. Clin Neuropharmacol 2014; 37 (5): 151-153
16. Foulkes AC, Wheeler L, Gosal D, etal. Development of chronic inflammatory demyelinating polyneuropathy in a patient receiving infliximab for psoriasis. Br J Dermatol 2014; 170 (1): 206-209
17. Nozaki K, Silver RM, Stickler DE, et al. Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. Am J Med Sci 2011; 342 (5); 352-355
18. Marcela C, Miguel G, Sergio J. Successful rechallenge with anti-tumor necrosis factor for psoriatic arthritis after development of demyelinating nervous system disease during initial treatment: comment on the article by Mohan et al. Arthritis & Rheumatism 2002; 46 (11): 3102-3114
19. Chroni E, Georgiou S, Polychronopoulos P, et al. Peripheral large nerve fibre function in patients with chronic plaque psoriasis. Eur J Neurol 2007; 14 (1): 18-20
20. Stern RS, Nijsten T, Feldman SR, et al. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139
21. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-850
22. Sampogna F, Tabolli S, Mastroeni S, et al. Quality of life impairment and psychological distress in elderly patients with psoriasis. Dermatology 2007; 215: 341-347
23. Kikta SV, Drobizhev MY, Belousov ТА. Depression in patients with psoriasis. Farmateka 2010; 11
24. Langan SM, Seminara NM, Shin DB, et al. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2012; 132: 556-562
25. Armstrong AW, Schupp C, Bebo B. Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology 2012; 225: 121-126
26. Dermatovenerologists' and Cosmetologists' Society. Federal clinical recommendations for the treatment of patients with psoriasis. Moscow, 2015.
27. Dougados М, Linden S van der, Juhlin R, et al. The European Spondyloarthropathy Study Group preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum.1991;34(10): 1218-27
28. Nasonova V.A., Bunchuk N.V., eds. Lections about clinical reumatology. M.: Medicine, 2001
29. Manger В. Checkliste XX 3. — 15. Auflage — Stuttgart — New York: Georg Thieme Verlag. L Rheumatologie, 2005; 586 p.

2016_02-1_300-303.pdf275.61 KB

No votes yet